Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and kinase inhibitors for cancer treatment. Its boronic acid group enables Suzuki-Miyaura cross-coupling reactions, making it valuable in constructing biaryl structures in drug discovery. Also employed in the preparation of PET radiotracers due to its ability to form stable complexes with imaging isotopes. Commonly utilized in medicinal chemistry for modifying peptide-based drugs to enhance stability and binding affinity.